Skip to main content
. 2020 Aug 10;14(8):e0008482. doi: 10.1371/journal.pntd.0008482

Fig 7. Representative IVIS images of mice treated for 10 days with different schedules and doses of azelastine or fexofenadine and the anti-leishmanial drug miltefosine.

Fig 7